• 1. Establishing plasmon contribution to chemical reactions: alkoxyamines as a thermal probe?
  Olga Guselnikova,Gérard Audran,Jean-Patrick Joly,Andrii Trelin,Evgeny V. Tretyakov,Vaclav Svorcik,Oleksiy Lyutakov,Sylvain R. A. Marque Chem. Sci., 2021,12, 4154-4161
• 2. Excimer and exciplex formation in a pair of bright phosphorescent isomers constructed from Cu3(pyrazolate)3 and Cu3I3 coordination luminophores?
  Shun-Ze Zhan,Mian Li,Xiao-Ping Zhou,Dan Li,Seik Weng Ng RSC Adv., 2011,1, 1457-1459
• 3. Distinct impact of glycation towards the aggregation and toxicity of murine and human amyloid-β?
  Eunju Nam,Jiyeon Han,Sunhee Choi,Mi Hee Lim Chem. Commun., 2021,57, 7637-7640
• 4. Excited state dynamics of symmetric and asymmetric Cr3(dpa)4Cl2 measured using femtosecond transient absorption spectroscopy?
  Chao-Han Cheng,Wen-Zhen Wang,Shie-Ming Peng,I-Chia Chen Phys. Chem. Chem. Phys., 2017,19, 25471-25477
• 5. Fast-pulsing NMR techniques for the detection of weak interactions: successful natural abundance probe of hydrogen bonds in peptides?
  Amandine Altmayer-Henzien,Valérie Declerck,David J. Aitken,Ewen Lescop,Denis Merlet,Jonathan Farjon Org. Biomol. Chem., 2013,11, 7611-7615

4-Ethyl-6-ethynyl-5-fluoropyrimidine (CAS No. 1936224-13-3): A Key Intermediate in Modern Pharmaceutical Synthesis

4-Ethyl-6-ethynyl-5-fluoropyrimidine, identified by its CAS number 1936224-13-3, is a significant intermediate in the realm of pharmaceutical chemistry. This compound, characterized by its fluoropyrimidine core structure, has garnered considerable attention due to its versatile applications in drug development. The presence of both ethyl and ethynyl substituents enhances its reactivity, making it a valuable building block for synthesizing a wide array of bioactive molecules.

The< strong>fluorine atom in the pyrimidine ring contributes to the compound's unique electronic properties, which are highly desirable in medicinal chemistry. Fluorinated pyrimidines are known for their ability to improve metabolic stability, binding affinity, and overall pharmacological efficacy. This has led to extensive research into their incorporation into drug candidates targeting various diseases, including cancer and infectious disorders.

In recent years, the pharmaceutical industry has witnessed a surge in the use of heterocyclic compounds like pyrimidines due to their broad biological activity. The synthesis of 4-Ethyl-6-ethynyl-5-fluoropyrimidine involves multi-step organic transformations that highlight the compound's synthetic utility. Researchers have leveraged its reactive sites to develop novel methodologies for constructing complex molecular architectures. For instance, the ethynyl group can undergo Sonogashira coupling reactions, while the ethyl moiety allows for further functionalization via Grignard or other organometallic reactions.

The< strong>CAS no. 1936224-13-3 designation ensures that this compound is well-documented in chemical literature and databases, facilitating its use in both academic and industrial research settings. The growing interest in fluorinated pyrimidines has spurred innovation in synthetic strategies, with reports of more efficient and scalable production methods. These advancements are crucial for meeting the increasing demand for high-quality intermediates in drug discovery pipelines.

A notable application of 4-Ethyl-6-ethynyl-5-fluoropyrimidine lies in the development of antiviral and anticancer agents. The structural features of this compound make it an excellent candidate for designing molecules that interact with biological targets such as enzymes and receptors. Recent studies have demonstrated its role in synthesizing inhibitors that exhibit potent activity against viruses like HIV and hepatitis C. Additionally, derivatives of this compound have shown promise in targeting kinases and other enzymes involved in cancer progression.

The< strong>ethynyl functionality is particularly noteworthy for its ability to form stable triple bonds with various substrates. This property has been exploited in the development of click chemistry approaches, where rapid and efficient bond-forming reactions are essential. Such methodologies have found widespread use in drug discovery, allowing researchers to construct complex molecules with minimal synthetic overhead. The combination of these attributes makes 4-Ethyl-6-ethynyl-5-fluoropyrimidine a cornerstone in modern pharmaceutical synthesis.

In conclusion, CAS no. 1936224-13-3, referring to 4-Ethyl-6-ethynyl-5-fluoropyrimidine, represents a pivotal intermediate with far-reaching implications in medicinal chemistry. Its unique structural features and reactivity profile have positioned it as a key component in the synthesis of bioactive molecules targeting diverse therapeutic areas. As research continues to uncover new applications and synthetic strategies, this compound is poised to remain at the forefront of pharmaceutical innovation.

• 2098070-20-1(2-(3-(Pyridin-3-yl)-1H-pyrazol-1-yl)acetimidamide)
• 2680771-01-9(4-cyclopentyl-3-{(prop-2-en-1-yloxy)carbonylamino}butanoic acid)
• 1444113-98-7(N-(3-cyanothiolan-3-yl)-2-[(2,2,2-trifluoroethyl)sulfanyl]pyridine-4-carboxamide)
• 332062-08-5(Fmoc-S-3-amino-4,4-diphenyl-butyric acid)
• 1270529-38-8(1,2,3,4,5,6-Hexahydro-[2,3]bipyridinyl-6-ol)
• 941977-17-9(N'-(3-chloro-2-methylphenyl)-N-2-(dimethylamino)-2-(naphthalen-1-yl)ethylethanediamide)
• 2138166-62-6(2,2-Difluoro-3-[methyl(2-methylbutyl)amino]propanoic acid)
• 89640-58-4(2-Iodo-4-nitrophenylhydrazine)
• 1449132-38-0(3-Fluoro-5-(2-fluoro-5-methylbenzylcarbamoyl)benzeneboronic acid)
• 2034271-14-0(2-(1H-indol-3-yl)-N-{[6-(thiophen-2-yl)-[1,2,4]triazolo[4,3-b]pyridazin-3-yl]methyl}acetamide)